Immune phase transition under steroid treatment

Area of Science:

• Immunology
• Systems Biology
• Mathematical Biology

Background:

• Glucocorticoids (GC) are potent immunosuppressants impacting T-cell-mediated adaptive immunity.
• Understanding the long-term dynamics of pro-inflammatory (T_pro) and anti-inflammatory (T_anti) T-cells under GC influence is crucial for clinical applications.

Purpose of the Study:

• To develop a minimal kinetic network model to quantitatively analyze long-term GC effects on T_pro and T_anti cell populations.
• To characterize immune regulation based on T_pro:T_anti ratios and identify distinct dynamical phases.

Main Methods:

• Developed a minimal kinetic network model of T-cell regulation.
• Analyzed steady-state outcomes and pre-steady-state dynamics under varying GC levels.
• Investigated the relationship between GC dosage, T-cell ratios, and the clinical latent period.

Main Results:

• Identified three immune regulation regimes (weak, strong, moderate) based on T_pro:T_anti ratios, exhibiting bistability.
• Observed a distinct intermediate stationary phase (clinical latent period) in moderate regulation.
• Determined an optimal GC level for transitioning to moderate regulation, balancing T_pro and T_anti cells and prolonging the latent period.

Conclusions:

• The study provides a quantitative framework for understanding GC's long-term impact on immune balance.
• The clinical latent period's sensitivity to GC levels suggests its utility as an early diagnostic warning signal for immune status.
• Findings support long-term immune diagnostics and tailored steroid treatment strategies based on immune phase.